Clinical Trials on Heterogeneous Emphysema in Australia
Total 33 results
-
Uptake Medical CorpCompletedEmphysemaAustralia, Ireland, Germany, Austria, New Zealand, United Kingdom
-
Pulmonx CorporationRecruitingEmphysema or COPD | Emphysema, PulmonarySpain, Germany, Italy, Australia
-
Apreo Health, Inc.RecruitingEmphysema or COPDAustralia
-
Uptake Medical CorpCompletedChronic Obstructive Pulmonary Disease | EmphysemaGermany, Ireland, Australia, Austria
-
Pulmonx CorporationActive, not recruitingPulmonary EmphysemaAustralia
-
Baxalta now part of ShireCompletedAlpha 1-Antitrypsin DeficiencyNew Zealand, Australia
-
Baxalta now part of ShireBaxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)CompletedAlpha 1-Antitrypsin DeficiencyAustralia, New Zealand
-
Apreo Health, Inc.RecruitingEmphysema or COPDUnited Kingdom, Austria, Netherlands
-
LudwLudwig Boltzmann Institute for COPD and Respiratory...UnknownLung Diseases | Pulmonary Emphysema | COPDAustria
-
Pulmonx CorporationActive, not recruitingEmphysema | COPD | Severe EmphysemaUnited Kingdom, France, Netherlands, Germany, Australia, Italy, Switzerland
-
Pulmonx International SàrlCompletedCOPD Patients With Homogeneous Emphysema | Endoscopic Lung Volume Reduction With Endobronchial ValveGermany, Austria, Netherlands
-
Grifols Therapeutics LLCActive, not recruitingPulmonary Emphysema in Alpha-1 PI DeficiencyUnited States, Australia, Denmark, New Zealand, Estonia, Poland, Russian Federation, Sweden, Brazil, Canada, France, Finland
-
CSL BehringCompletedEmphysema | Alpha1-proteinase Inhibitor DeficiencyAustralia, Russian Federation, United States, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden, Canada, Czech Republic
-
Uptake Medical Technology, Inc.Recruiting
-
Arrowhead PharmaceuticalsTerminatedAlpha-1 Antitrypsin DeficiencyAustralia, Netherlands, Germany, United Kingdom
-
LudwLudwig Boltzmann Institute for COPD and Respiratory...UnknownChronic Obstructive Pulmonary Disease | EmphysemaAustria, Belgium
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
Pulmonx CorporationCompletedEmphysemaNetherlands, Germany, Austria
-
Inhibrx, Inc.RecruitingEmphysema | Alpha 1-Antitrypsin DeficiencyUnited States, Australia, United Kingdom, New Zealand
-
Isabelle Opitz, Professor, MDRecruitingSurgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema (SINCERE)EmphysemaBelgium, Switzerland, Denmark, Austria
-
Broncus TechnologiesUnknownEmphysemaUnited States, Spain, Australia, Canada, Ireland, United Kingdom, Austria, Brazil, Germany, Netherlands
-
Aeris TherapeuticsTerminatedEmphysema | Chronic Pulmonary Obstructive DiseaseGermany, Israel, Austria, France
-
Grifols Therapeutics LLCEnrolling by invitationPulmonary Emphysema in Alpha-1 Antitrypsin DeficiencyUnited States, New Zealand, Denmark, Australia, Finland, Estonia, Canada, Poland, Russian Federation, Sweden, France
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom, United States, Ireland, Belgium, New Zealand, Spain, Netherlands, Portugal, Canada, Australia, France, Austria, Germany, Sweden
-
Aeris TherapeuticsCompletedLung Diseases | Emphysema | Pulmonary Emphysema | Chronic Obstructive Pulmonary Disease (COPD)Israel, Austria, France, Germany
-
Arrowhead PharmaceuticalsActive, not recruitingAlpha 1-Antitrypsin DeficiencyAustria, Germany, United Kingdom
-
Boston Scientific CorporationPneumRx, Inc.CompletedEmphysemaUnited Kingdom, France, Germany, Netherlands, Italy, Austria
-
TakedaTakeda Development Center Americas, Inc.RecruitingAlpha1-Antitrypsin DeficiencyUnited States, Belgium, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Spain, Portugal, Italy, Poland
-
Boston Scientific CorporationPneumRx, Inc.TerminatedEmphysemaUnited Kingdom, Spain, Germany, Switzerland, Austria, Denmark
-
TakedaEnrolling by invitationAlpha1-Antitrypsin DeficiencyUnited Kingdom, Germany, United States, Austria, Portugal
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedChronic Obstructive Pulmonary Disease | Alpha1-antitrypsin DeficiencyUnited States, Canada, Australia
-
CSL BehringRecruitingAcute-graft-versus-host DiseaseUnited States, Korea, Republic of, Spain, Australia, Germany, Italy, Turkey, Japan